Aeterna Zentaris Inc (NASDAQ:AEZS)
| 0.207 Delayed Data As of May 27 |  +0.0015 / +0.73%Today’s Change | 0.18 Today|||52-Week Range 1.15 | -41.74% Year-to-Date |
Latest AEZS News | Press Releases
No recent news for Aeterna Zentaris Inc.
Today’s Trading
| Previous close | 0.21 |
| Today’s open | 0.21 |
| Day’s range | 0.21 - 0.21 |
| Volume | 6,836 |
| Average volume (3 months) | 643,933 |
| Market cap | $24.1M |
Data as of 3:55pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | +41.57% |
| Earnings growth (this year) | -57.14% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +44.03% |
| P/E ratio | NM |
| Price/Sales | 7.87 |
| Price/Book | 0.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --ImmuPharma PLC | 0.00 | 0.00% |
| ZIVOZivo Bioscience Inc | +0.22 | +7.64% |
| OPGNOpGen Inc | +0.08 | +16.62% |
| RKDAArcadia Biosciences ... | +0.09 | +7.14% |
Data as of 3:59pm ET, 05/27/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $5.3M |
| Annual profit (last year) | -$8.4M |
| Net profit margin | -159.09% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Toronto, Ontario |
Forecasts
